List of AIDS-related topics

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition. 

A
AACTG - acquired immunity - acquired immunodeficiency syndrome (AIDS) - ACTIS - ACT UP/Golden Gate - active immunity - acupuncture - acute HIV infection - Acute HIV Infection and Early Diseases Research Program (AIEDRP) - ADAP - ADC - adenopathy - adherence - adjuvant - administration - Adult AIDS Clinical Trials Group (AACTG) - adverse reaction - aerosolized - AETC - affected community - agammaglobulinemia - Agency for Healthcare Research and Quality (AHRQ) - AHRQ - AIDS - AIDS dementia complex (ADC) - AIDS Drug Assistance Programs (ADAP) - AIDS education and training centers (AETC) - AIDS Law Project - AIDS research advisory committee (ARAC) - AIDS service organization (ASO) - The AIDS Show - AIDS wasting syndrome - AIDS-related cancer - AIDS-related complex (ARC) - aidsdrugs - aidsline - aidstrials - alkaline phosphatase - alopecia - alpha interferon (INFa) - alternative medicine - alveolar - amebiasis - amino acids - anaphylactic shock - anemia - anergy - angiogenesis - angiomatosis - anorexia - antenatal - antibiotic - antibodies - antibody-dependent cell-mediated cytotoxicity (ADCC) - antibody-mediated immunity - antifungal - antigen - antigen presentation - antigen-presenting cell (APC) - antineoplastic - antiprotozoal - antiretroviral drugs - antisense drugs - antitoxins - antiviral - aphasia - aphthous ulcer - apoptosis - approved drugs - ARC - ARM - Armenicum - ART - arthralgia - ASO - aspergillosis - assembly and budding - asymptomatic - ataxia - attenuated - autoantibody - autoimmunization - autoinoculation - autologous - avascular necrosis (AVN) - AVN -

B
B cell lymphoma - B cells - B lymphocytes (B cells) - bactericidal - bacteriostatic - bacterium - baculovirus - baseline - basophil - bDNA test - beta-2 microglobulin (β2M) - bilirubin - binding antibody - bioavailability - biological response modifiers (BRMs) - biopsy - biotechnology - blind study - blips - blood-brain barrier - body fat redistribution (BFR) syndrome - body fluids - bone marrow - bone marrow suppression - booster - branched DNA assay - breakthrough infection - Broadway Cares/Equity Fights AIDS - bronchoscopy - budding - buffalo hump - bugchasing and giftgiving - Burkitt's lymphoma -

C
C-T scan (computed tomography scan) - cachexia - Canadian Foundation for AIDS Research - candida - candidiasis - carcinogen - cat scan - CBCT - CBO - CCR5 - CD4 (T4) or CD4 + cells - CDC National AIDS Hotline (CDC-NAH) - CDC National Prevention Information Network (CDC-NPIN) - cell lines - cell-mediated immunity (CMI) - cellular immunity - Centers for Disease Control and Prevention (CDC) - Centers for Medicare and Medicaid Services (CMS) - central nervous system - central nervous system (CNS) damage - cerebral - cerebrospinal fluid (CSF) - cervical cancer - cervical dysplasia - cervical intraepithelial neoplasia (CIN1, CIN2, CIN3) - cervix - challenge (medicine) - chancroid - chemokines - chemoprophylaxis - chemotherapy - Chlamydia - chronic idiopathic demyelinating polyneuropathy (CIPD) - Circumoral paresthesia - clade - clinical - clinical alert - clinical endpoint - clinical latency - clinical practice guidelines - clinical trial - clinical trials information service (aidsinfo) - clinicaltrials.gov - cloning - CMS - CMV - CNS - co-receptors - coccidioidomycosis - codon - cofactors - cognitive impairment - cohort - colitis - combination therapy - community planning - Community Programs for Clinical Research on AIDS (CPCRA) - community-based clinical trial (CBCT) - community-based organization (CBO) - compassionate use - complement - complement cascade - complementary and alternative therapy - complete blood count (CBC) - computed tomography scan (C-T scan) - concomitant drugs - condyloma - condyloma acuminatum - contagious - contraindication - controlled trials - core - core protein - correlates of immunity/correlates of protection - CPCRA - creatinine - cross-resistance - cryotherapy - cryptococcal meningitis - cryptococcosis - Cryptococcus neoformans - cryptosporidiosis - Cryptosporidium - CSF - CTL - cutaneous - CXCR4 - cytokines - cytomegalovirus (CMV) - Cytomegalovirus retinitis - cytopenia - cytotoxic - cytotoxic T lymphocyte (CTL) -

D
DAIDS - data safety and monitoring board (DSMB) - deletion - dementia - demyelination - dendrite - dendritic cells - deoxyribonucleic acid (DNA) - Department of Health and Human Services (DHHS/HHS or DHHS) - desensitization - diabetes mellitus (DM) - diagnosis - diarrhea - diplopia - dissemination - division of acquired immunodeficiency syndrome (DAIDS) - DNA - Domain (biology) - dose-ranging study - dose-response relationship - double burden of disease - double-blind study - drug resistance - drug-drug interaction - DSMB - dysplasia - dyspnea -

E
efficacy - empirical - encephalitis - end-stage disease - endemic - endogenous - endoscopy - endotoxin - endpoint - enteric - enteritis - entry inhibitors - Env - envelope - enzyme - enzyme-linked immunosorbent assay (ELISA) - eosinophil - eosinophilic folliculitis - epidemic - epidemiological surveillance - epidemiology - epithelium - epitope - Epstein-Barr virus (EBV) - erythema - erythema multiforme - erythrocytes - etiology - exclusion/inclusion criteria - exogenous - exotoxin - expanded access - experimental drug - expression system -

F
fat redistribution - FDA - FDC - floaters - follicle - follicular dendritic cells (FDCs) - food and drug administration (FDA) - functional antibody - fungus - fusin - fusion inhibitor - fusion mechanism -

G
GAG - gamma globulin - gamma interferon - ganglion - GART - gastrointestinal (GI) - gene - gene therapy - genetic engineering - genital ulcer disease - genital warts - genitourinary tract - genome - genotypic assay - germinal centers - giardiasis - globulins - glycoprotein - gonorrhea - gp120 (gp120) - gp160 (gp160) - gp41 (gp41) - granulocyte - granulocyte macrophage-colony stimulating factor (GM-CSF) - granulocyte-colony stimulating factor (G-CSF) - granulocytopenia -

H
HAART - hairy leukoplakia - half-life - HAM/TSP - HCSUS - Health Care Financing Administration (HCFA) - Health Resources and Services Administration (HRSA) - HELLP syndrome - helper T cells - helper/suppressor ratio (of T cells) - hematocrit - hematotoxic - hemoglobin - hemolysis - hemophilia - hepatic - hepatic steatosis - hepatitis - hepatitis C/co-infection with HIV - hepatomegaly - herpes simplex virus 1 (HSV-1) - herpes simplex virus 2 (HSV-2) - herpes varicella zoster virus (VZV) - herpes viruses - highly active antiretroviral therapy (HAART) - histocompatibility testing - histoplasmosis - HIV Cost and Services Utilization Study (HCSUS) - HIV disease - HIV prevention trials network (HPTN) - HIV set point - HIV vaccine trials network (HVTN) - HIV-1 - HIV-2 - HIV-associated dementia - HIV-related tuberculosis - HLA - Hodgkin's disease - holistic medicine - homology (biology) - hormone - host - host factors - HPTN - HPV - HRSA - HTLV-I - HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) - HTLV-II - human growth hormone (HGH) - human immunodeficiency virus type 1 (HIV-1) - human immunodeficiency virus type 2 (HIV-2) - human leukocyte antigens (HLA) - human papilloma virus (HPV) - human T cell lymphotropic virus type I (HTLV-I) - human T cell lymphotropic virus type II (HTLV-II) - humoral immunity - HVTN - hydroxyurea - hypergammaglobulinemia - hyperglycemia - hyperlipidemia - hyperplasia - hyperthermia - hypogonadism - hypothesis - hypoxia -

I
idiopathic - idiopathic thrombocytopenia purpura - IHS - immune complex - immune deficiency/immunodeficiency - immune response - immune system - immune thrombocytopenic purpura - immunity - immunization - immunocompetent - immunocompromised - immunodeficiency - immunogen - immunogenicity - immunoglobulin (Ig) - immunoglobulin A (IgA) - immunoglobulin D (IGD) - immunoglobulin E (IGE) - immunoglobulin G (IGG) - immunoglobulin M (IGM) - immunomodulator - immunostimulant - immunosuppression - immunotherapy - immunotoxin - in vitro - in vivo - incidence - inclusion/exclusion criteria - Incubation period - IND - Indian Health Service (IHS) - infection - infectious - informed consent - infusion - inoculation - institutional review board (IRB) - integrase - integrase inhibitors - integration - intensification - intent to treat - interaction - interferon - interleukin-1 (IL-1) - interleukin-2 (IL-2) - interleukin-4 (IL-4) - interleukin-12 (IL-12) - interleukins - International Center for Research on Women - interstitial - intramuscular (IM) - intrapartum - intravenous - intravenous immunoglobulin (IVIG) - intravitreal - Investigational New Drug (IND) - IRB - isolate - ITP - IVIG -

J
jaundice - JC virus -

K
Kaposi's sarcoma (KS) - Karnofsky score - killer T cells - KSHV - Kupffer cells -

L
LAI - Langerhans cells - LAS - lentivirus - lesion - leukocytes - leukocytosis - leukopenia - leukoplakia - LFT - LIP - lipid - lipodystrophy - liposomes - live vector vaccine - liver function test (LFT) - LOG - long terminal repeat sequence (LTR) - long-term nonprogressors - LTR - lumbar - lumbar puncture - lymph - lymph nodes - lymphadenopathy syndrome (LAS) - lymphatic vessels - lymphocyte - lymphoid interstitial pneumonitis (LIP) - lymphoid organs - lymphoid tissue - lymphokine-activated killer cells (LAK) - lymphokines - lymphoma - lymphopenia - lymphoproliferative response - lysis -

M
MAC - macrophage - macrophage-tropic virus - magnetic resonance imaging (MRI) - MAI - maintenance therapy - major histocompatibility complex (MHC) - malabsorption syndrome - malaise - malignant - mast cell - MedlinePlus - mega-HAART - memory T cells - meninges - meningitis - messenger RNA - metabolism - metastasis - MHC - microbes - microbicide - Microsporidiosis - mitochondria - mitochondrial toxicity - molecule - molluscum contagiosum - monocyte - mononeuritis multiplex (MM) - monovalent vaccine - morbidity - MRI - mucocutaneous - mucosa - mucosal immunity - mucous membrane - multi-drug rescue therapy - multiple drug-resistant tuberculosis (MDR-TB) - mutation - myalgia - mycobacterium - mycobacterium avium complex (MAC) - mycosis - myelin - myelopathy - myelosuppression - myelotoxic - myocardial - myopathy -

N
NADIR - NAT - National AIDS Hotline - National Cancer Institute (NCI) - National Institute of Allergy and Infectious Diseases (NIAID) - National Institute of Child Health and Human Development (NICHD) - National Institutes of Health (NIH) - National Library of Medicine (NLM) - National Prevention Information Network (NPIN) - natural history study - natural killer cells (NK cells) - NCI - New Drug Application - nebulized - NEF - neonatal - neoplasm - nephrotoxic - neuralgia - neurological complications of AIDS - neuropathy - neutralization - neutralizing antibody - neutralizing domain - neutropenia - neutrophil - New Drug Application (NDA) - New York Cares - NIAID - NICHD - night sweat - NIH - NK cell - NLM - NNRTI - non-Hodgkin's lymphoma (NHL) - non-nucleoside reverse transcriptase inhibitors (NNRTI) - non-steroidal anti-inflammatory drugs (NSAID) - NRTI - nucleic acid - nucleic acid test - nucleocapsid - nucleoli - nucleoside - nucleoside analog - nucleoside reverse transcriptase inhibitors (NRTI) - nucleotide - nucleotide analogs - nucleus - null cell -

O
ocular - off-label use - Office of AIDS Research (OAR) - OI - oncology - open-label trial - opportunistic infections - oral hairy leukoplakia (OHL) - organelle - oropharyngeal - orphan drugs - osteonecrosis - osteopenia -

P
P24 - package insert - palliative - palliative care - pancreas - pancreatitis - pancytopenia - pandemic - pap smear - papilloma - parallel track - parasite - parenteral - paresthesia - passive immunity - passive immunotherapy - pathogen - pathogenesis - PBMC - PCP - PCR - Pediatric AIDS Clinical Trial Group (PACTG) - pelvic inflammatory disease - peptide - perianal - perinatal - perinatal transmission - peripheral neuritis - peripheral neuropathy - persistent generalized lymphadenopathy - person with AIDS (PWA) - PGL - phagocyte - phagocytosis - pharmacokinetics - phase I trials - phase II trials - phase III trials - phase IV trials - phenotypic assay - photosensitivity - PHS - pituitary gland - placebo - placebo controlled study - placebo effect - plasma - plasma cells - platelets - PML - Pneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) - POL - polymerase - polymerase chain reaction (PCR) - polyneuritis - polypeptide - polyvalent vaccine - post-exposure prophylaxis (PEP) - PPD test - pre-conception counseling - preclinical - precursor cells - prevalence - primary HIV infection - primary isolate - primaquine - proctitis - prodrome - prodrug - progressive multifocal leukoencephalopathy (PML) - prophylactic drug - prophylaxis - protease - protease inhibitors - protease-sparing regimen - proteins - protocol - protozoa - provirus - pruritus - pseudo-Cushing's syndrome - pseudovirion - PUBMED - pulmonary - purified protein derivative (PPD) -

R
radiology - randomized trial - rebound - receptor (immunology) - recombinant - recombinant DNA - recombinant DNA technology - refractory (medicine) - regulatory genes - regulatory T cells - remission - renal - rescue therapy - resistance - resistance testing - retina - retinal detachment - retinitis - retrovirus - REV - reverse transcriptase - ribonucleic acid (RNA) - ribosome - RNA - route of administration - RT-PCR - RTI - Ryan White C.A.R.E. act -

S
safe sex - safer sex - salmonella - salvage therapy - SAMHSA - sarcoma - seborrheic dermatitis - secondary prophylaxis - sepsis - seroconversion - serologic test - seroprevalence - serosorting -- serostatus - serum - serum glutamic oxaloacetic transaminase (SGOT) - serum glutamic pyruvate transaminase (SGPT) - set point - sexually transmitted disease (STD) - shingles - SHIV - side effects - simian immunodeficiency virus (SIV) - sinusitis - SIT - SIV - Special Projects of National Significance (SPNS) - spinal tap - spleen - splenomegaly - sputum analysis - standard of care - staphylococcus - STD - stem cells (FDCs) - steroid - Stevens-Johnson syndrome - STI - stomatitis - strain - stratification - structured intermittent therapy (SIT) - structured treatment interruption (STI) - study endpoint - subarachnoid space - subclinical infection - subcutaneous (SQ) - Substance Abuse and Mental Health Services Administration (SAMHSA) - subunit HIV vaccine - sulfa drug - sulfonamides - superantigen - suppressor T cell - surrogate marker - surveillance - susceptible - symptoms - syncytium - syndrome - synergism - synergistic - synthesis - syphilis - systemic -

T
T cells (T lymphocytes) - T lymphocyte proliferation assay - T lymphocytes - T suppressor cells - T4 cell - T4 cells (T-helper cells) - T8 cells - Tanner staging - TAT - TB - template - teratogenicity - Terry Beirn Community Programs for Clinical Research on AIDS - testosterone - therapeutic HIV vaccine - thrombocytopenia - thrush - thymosin - thymus - tissue - titer - toxicity - toxoplasmic encephalitis - toxoplasmosis - transaminase - transcription - transfusion - translation - transmission - transplacental - treatment IND - triglycerides - tuberculin skin test (TST) - tuberculosis (TB) - tumor necrosis factor (TNF) -

V
V3 loop - vaccination - vaccine - vaccinia - vaginal candidiasis - valley fever - variable region - varicella zoster virus (VZV) - vector - vertical transmission - viral burden - viral core - viral culture - viral envelope - viral load - viremia - viricide - virion - virology - virus - visceral -

W
wasting syndrome - Western blot - white blood cells - wild-type virus - window period - Women's Interagency HIV Study (WIHS) -

Y
yeast infection -

Z
zinc finger inhibitor - zinc fingers -